Evidence map›Paper›PMID 22280344›Full record

ReviewCurrent drug targets2012

Novel and viable acetylcholinesterase target site for developing effective and environmentally safe insecticides.

Yuan-Ping Pang, Stephen Brimijoin, David W Ragsdale, Kun Yan Zhu, Robert Suranyi

Open access · bronzeAbstract readReview
In one paragraph

Review in Current drug targets, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Essential Oils of Two Subspecies ofMolecules (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Acaricidal, Insecticidal, and Nematicidal Efficiency of Essential Oils Isolated from theInternational journal of environmental research and public health · 2021
    Review
  12. Article
  13. Article
  14. Cysteine-Targeted Insecticides againstACS medicinal chemistry letters · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Yuan-Ping PangMolecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA. pang@mayo.edu
Stephen Brimijoin
David W Ragsdale
Kun Yan Zhu
Robert Suranyi
Mayo Clinic · USKansas State University · USMcLaughlin Research Institute · USTwin Cities Orthopedics · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insect pests are responsible for human suffering and financial losses worldwide. New and environmentally safe insecticides are urgently needed to cope with these serious problems. Resistance to current insecticides has resulted in a resurgence of insect pests, and growing concerns about insecticide toxicity to humans discourage the use of insecticides for pest control. The small market for insecticides has hampered insecticide development; however, advances in genomics and structural genomics offer new opportunities to develop insecticides that are less dependent on the insecticide market. This review summarizes the literature data that support the hypothesis that an insect-specific cysteine residue located at the opening of the acetylcholinesterase active site is a promising target site for developing new insecticides with reduced off-target toxicity and low propensity for insect resistance. These data are used to discuss the differences between targeting the insect-specific cysteine residue and targeting the ubiquitous catalytic serine residue of acetylcholinesterase from the perspective of reducing off-target toxicity and insect resistance. Also discussed is the prospect of developing cysteine-targeting anticholinesterases as effective and environmentally safe insecticides for control of disease vectors, crop damage, and residential insect pests within the financial confines of the present insecticide market.

Indexed as

Drug DesignAcetylcholinesteraseAnimalsDrug Delivery SystemsEnvironmental ExposureGenomicsHumansInsect ControlInsecticide ResistanceInsecticidesInsect VectorsAcetylcholinesteraseInsecticides

Identifiers

PMID22280344
PMCPMC3343382
OpenAlexW2129343911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.